Efficacy and effectiveness of percutaneous tibial nerve stimulation in the treatment of pelvic organ disorders: A systematic review

Neuromodulation

Volumn 16, Issue 1, 2013, Pages 25-34

  Biemans, Johanna M A E ^a   Van Balken, Michael R ^b  

^a Private Clinic for Physiotherapy and Acupuncture   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Fecal incontinence; overactive bladder; pelvic organ disorders; percutaneous tibial nerve stimulation; peripheral neuromodulation

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; TOLTERODINE;

ADVERSE OUTCOME; BLURRED VISION; CLINICAL EFFECTIVENESS; CONSTIPATION; FECES INCONTINENCE; FOLLOW UP; HEMATOMA; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE DISCOMFORT; INTENTION TO TREAT ANALYSIS; NERVE STIMULATION; NOCTURIA; OVERACTIVE BLADDER; PATIENT SAFETY; PELVIS PAIN SYNDROME; PERCUTANEOUS TIBIAL NERVE STIMULATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE; XEROSTOMIA;

EID: 84873405063     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2012.00504.x     Document Type: Review

References (44)

1. NHS, National Institute for Health and Clinical Excellence. Treating an overactive bladder by stimulating a nerve near the ankle. October 2010.
2. McGuire EJ, Zhang SC, Horwinski ER, Lytton B,. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol 1983; 129: 78-79.
3. Bernstein AJ, Peters KM,. Expanding indications for neuromodulation. Urol Clin North Am 2005; 32 (1): 59-63.
4. Tubaro A, Palleschi G,. Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynaecol 2005; 17: 507-511.
5. DeRogatis LR, Burnett AL,. The epidemiology of sexual dysfunctions. J Sex Med 2008; 5: 289-300.
6. Irwin DE, Milsom I, Hunskaar S, et al,. Population-based survey of urinary incontinence, overactive bladder and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50: 1306-1314; discussion 1314-5.
7. Aitola P, Lehto K, Fonsell R, Huhtala H,. Prevalence of faecal incontinence in adults aged 30 years or more in general population. Colorectal Dis 2010; 12: 687-691.
8. Irwin DE, Milsom I, Reilly K, et al,. Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med 2008; 5: 2904-2910.
9. Waldinger MD, Schweitzer DH,. Persistent genital arousal disorder in 18 Dutch women: Part II. A syndrome clustered with restless legs and overactive bladder. J Sex Med 2009; 6: 482-497.
10. van Balken MR, Vergunst H, Bemelmans BL,. Sexual functioning in patients with lower urinary tract dysfunction improves after percutaneous tibial nerve stimulation. Int J Impot Res 2006; 18: 470-475.
11. van der Pal F, Heesakkers JPFA, Bemelmans BLH,. Current opinion on the working mechanism of neuromodulation in the treatment of lower urinary tract dysfunction. Curr Opin Urol 2006; 16: 261-267.
12. Dharmesh S, Kapoor Æ, Ranee Thakar Æ, Abdul HS,. Combined urinary and faecal incontinence. Int J Urogynecol 2005; 16: 321-328.
13. Ridout AE, Yoong W,. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy. J Obstet Gynaecol 2010; 30: 111-114.
14. van Balken MR, Vandoninck V, Gisolf KWH, et al,. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol 2001; 166: 914-918.
15. Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P,. Percutaneous afferent neuromodulation for refractory overactive bladder: results of a multicenter study. J Urol 2001; 165: 1193-1198.
16. Boyle DJ, Prosser KBN, Allison ME, Williams NS, Chan CLH,. Percutaneous tibial nerve stimulation for the treatment of urge fecal incontinence. Dis Colon Rectum 2010; 53: 432-437.
17. de la Portilla F, Rada R, Vega J, González CA, Cisheros N, Maldonado VH,. Evaluation of the use of posterior tibial nervestimulation for the treatment of fecal incontinence: preliminary results of a prospective study. Dis Colon Rectum 2009; 52: 1427-1433.
18. van Balken MR, Vandoninck V, Messelink BJ, et al,. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur Urol 2003; 43: 158-163.
19. Kim S, Paick J, Ku J,. Percutaneous posterior tibial nerve stimulation in patients with chronic pelvic pain: a preliminary study. Urol Int 2007; 78: 58-62.
20. Zhao J, Nordling J,. Posterior tibial nerve stimulation in patients with intractable interstitial cystitis. BJU Int 2004; 94: 101-104.
21. Zhao J, Bai J, Zhou Y, Qi G, Du L,. Posterior tibial nerve stimulation twice a week in patients with interstitial cystitis. Urology 2008; 71: 1080-1084.
22. Kabay SC, Kabay S, Yucel M, Ozden H,. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourol Urodyn 2009; 28: 62-67.
23. Kabay S, Kabay SC, Yucel M, et al,. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn 2009; 28: 964-968.
24. Tjon Eng Soe SH, Kopsky DJ, Jongen PJH, de Vet HC, Oei-Tan CL,. Multiple sclerosis patients with bladder dysfunction have decreased symptoms after electro-acupuncture. Mult Scler 2009; 15: 1376-1377.
25. Verhagen AP, de Vet HC, de Bie RA, et al,. The Delphi list; a criteria list or quality assessment of randomized controlled trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 1235-1241.
26. Vohra AK, Britchford A, Neale E, Husain I, Waterfall N,. The efficacy of Stoller afferent nerve stimulation in frequency/urgency syndrome: a randomized trial. 2002. ICS Congress, Heidelberg (Germany), abstract 217 (reference from Finazzi-Agrò, 2001).
27. Mazo EB, Krivoborodov GG,. Temporary sacral and tibial neuromodulation in treating patients with overactive urinary bladder. Zh Vopr Neiroktir Im N N Burdenko 2002; 1: 17-21. (Reference from Congregado, 2004).
28. Krivoborodov GG, Mazo EB, Shvarts PG,. Afferent stimulation of the tibial nerve in patients with hyperactive bladder. Urologiia 2002; 5: 36-39. (Further hand searching by authors from 2.).
29. Krivoborodov GG, Gekht AB, Korshunova ES,. Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with parkinson's disease. Urologiia 2006; 4: 3-6. (Abstract reveals the study included therapy-resistant patients) (Further hand searching by authors from 2.).
30. Karademir K, Baykal K, Sen B, Senkul T, Isederi C, Erden D,. A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation. Scand J Urol Nephrol 2005; 39: 230-233.
31. Peters KM, MacDiarmid SA, Wooldridge LS, et al,. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 2009; 182: 1055-1061.
32. Peters KM, Carrico DJ, Perez-Marrero RA, et al,. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010; 183: 1438-1443.
33. Sancaktar M, Ceyhan ST, Akyol I, et al,. The outcome of adding peripheral neuromodulation (Stoller afferent neuro-stimulation) to anti-muscarinic therapy in women with severe overactive bladder. Gynecol Endocrinol 2010; 26: 729-732.
34. Finazzi-Agrò E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove R,. Percutaneous tibial nerve stimulation on detrusor overactivity incontinence patients are not caused by a placebo effect: A randomized, a double blind, placebo controlled study. J Urol 2010; 184: 2001-2006.
35. Shafik A, Ahmed I, El-Sibai O, Mostafa RM,. Percutaneous peripheral neuromodulation in the treatment of fecal incontinence. Eur Surg Res 2003; 35: 103-107.
36. Kabay S, Kabay SC, Yucel M, Ozden M,. Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a sham-controlled comparative study. Urol Int 2009; 83: 33-38.
37. Peters K, Carrico D, Siegel S, Wooldridge L, MacDiarmid S,. Cross sectional review of effect of percutaneous tibial nerve stimulation on fecal incontinence: results from two recent overactive bladder trials. 2010. Poster, International Continence Society, Toronto, Canada.
38. Lee SH, Lee BC,. Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology 2009; 73: 1036-1041.
39. Ma YX, Ma LX, Liu XL, et al,. A comparative study on the immediate effects of electro acupuncture at Sanyinjiao (SP6), Xuanzhong (GB39) and a non-meridian point, on menstrual pain and uterine arterial blood flow, in primary dysmenorrhea patients. Pain Med 2010; 11: 1564-1575.
40. Liu CZ, Xie JP, Wang LP, et al,. Immediate analgesia effect of single point acupuncture in primary dysmenorrhea: a randomized controlled trial. Pain Med 2011; 12: 300-307.
41. Sikiru L, Shmaila H, Muhammed SA,. Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial. Int Braz J Urol 2008; 34: 708-713.
42. van Balken MR,. Percutaneous tibial nerve stimulation in lower urinary tract disorders. Proefschrift Vrije Universiteit Amsterdam, Maart 2007.
43. Cakmak YÖ, Akpbox drawings light down and leftnar IN, Yoldemir T, Cavdar S,. Decreasing bleeding due to uterine fibroid with electroacupuncture. Fertil Steril 2011; 96: e13-e15.
44. Claydon LS, Chesterton LS, Barlas P, Sim J,. Dose-specific effects of transcutaneous electrical nerve stimulation (TENS) on experimental pain: a systematic review. Clin J Pain 2011; 27: 635-647.